Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort | Zendy

Darunee Chotiprasitsakul | Zendy; Jennifer Han | Zendy; Sara E. Cosgrove | Zendy; Anthony Harris | Zendy; Ebbing Lautenbach | Zendy; Anna Conley | Zendy; Pam Tolomeo | Zendy; Jacqueleen Wise | Zendy; Pranita D. Tamma | Zendy

Open Access

Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort

Author(s) -

Darunee Chotiprasitsakul,

Jennifer Han,

Sara E. Cosgrove,

Anthony Harris,

Ebbing Lautenbach,

Anna Conley,

Pam Tolomeo,

Jacqueleen Wise,

Pranita D. Tamma

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix767

Subject(s) - bacteremia , medicine , interquartile range , propensity score matching , hazard ratio , odds ratio , retrospective cohort study , antibiotics , confidence interval , cohort , surgery , microbiology and biotechnology , biology

The recommended duration of antibiotic treatment for Enterobacteriaceae bloodstream infections is 7-14 days. We compared the outcomes of patients receiving short-course (6-10 days) vs prolonged-course (11-16 days) antibiotic therapy for Enterobacteriaceae bacteremia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research